Australia starts investigation into OpenAI Medicare breach
Amid this probe, experts point to the importance of airtight AI governance when implementing the technology in high-risk contexts.
Artificial Intelligence
ASCO26: AI innovations show promise in reducing the oncology RWD burden
Keeping pace with generative AI in pharmaceutical and healthcare organisations
Clinical trial experts cite trust and regulatory uncertainty as AI barriers
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
